A Brazilian research team has eliminated HIV from a patient’s body for 78 consecutive weeks using only medications, without ...

Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...

Gilead's Phase 3 ARTISTRY-1 trial shows its single-tablet HIV regimen of bictegravir and lenacapavir matches the efficacy and safety of current therapy.

Forty boxes recently arrived at a mostly empty lab space in University City where the Wistar Institute opened this month a research center that seeks to cure HIV. Soon, the boxes will be unpacked by a ...

Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...

Approved in the US as the world’s first twice-yearly HIV prevention shot, lenacapavir is now set to be made in India at a ...

The human immunodeficiency virus (HIV), the virus that causes healthy adults to become immunosuppressed, integrates its viral genetic code into the genome of the immune CD4+ T cells. While ...

Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, ...

APPLIN: After nearly 20 years in HIV care, I’ve seen that HIV follows people through every season of life. When life is stable, patients stay in care and maintain suppression, but when challenges ...

The claim: New $40,000 twice yearly shot is 'AIDS cure' A Dec. 2 Instagram post (direct link, archive link) shows a syringe extracting fluid from a vial and claims a cure has been developed for a ...